Navigation Links
Immune Pharmaceuticals Announces Second Quarter 2014 Financial Results and Provides Update on Bertilimumab Commencement of Phase II Clinical Trials
Date:8/14/2014

Pain AmiKet has Orphan Drug Designation for Post Herpetic Neuralgia (PHN).

Operating Results for the Quarter Ended June 30, 2014

  • As of June 30, 2014, we had approximately $3.2 million in cash. In addition, we have $5 million available to us in a revolving line of credit obtained from a related party in April 2014. In addition, in August 2014, we secured a $1 million additional investment. We believe these resources to be sufficient to fund our operations, anticipated capital expenditures, working capital and other financing requirements over the next twelve months.

  • Our loss from operations was approximately $3.0 million for the quarter ended June 30, 2014 (including $1.2 million of non-cash costs).

  • Our non-operating income was approximately $3.3 million for the quarter ended June 30, 2014, mainly due a decrease in the value of our derivative warrants issued in March 2014.

  • In June 2014, we amended certain terms of our Preferred C Convertible Stock. As a result of the amendment, all then outstanding Preferred C Stock, in the total value of $1.9 million, were reclassified from mezzanine equity into the stockholders equity of the Company. In consideration for their consent, a two-year warrant, valued at $0.4 million, was issued to the holders, such warrants were accounted for within our equity.

    On a per share basis, our total net loss was $0.03 per basic share for the quarter ended June 30, 2014, compared to a net loss of $0.65 per basic share for the quarter ended June 30, 2013.

About Immune Pharmaceuticals Inc.

Immune Pharmaceuticals Inc. applies a personalized approach to treatment, developing novel, highly targeted antibody therapeutics to improve the lives of patients with inflammatory diseases and cancer. The Company's lead product candidate, Bertilimumab, is in clinical development   for moderat
'/>"/>

SOURCE Immune Pharmaceuticals Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Novimmune Reports Successful Completion of Phase I trial for NI-0101
2. Immune Pharmaceuticals Commences Patient Screening For Bertilimumab Phase II Clinical Trial In Bullous Pemphigoid, A Rare Auto-Immune Disease Of The Skin
3. UMD Researcher Helps Arm the Immune System to Fight Cancer
4. Immunotherapies Will Continue to Dominate the Malignant Melanoma Drug Market with Sales of Immune Checkpoint Inhibitors Accounting for Majority of Sales in this Drug Class in 2022
5. BHI Elects MedImmunes Reg Seeto, M.D. to Board of Directors
6. Global Autoimmune Disease Diagnostics Market
7. NW Bio Responds To Shareholder Inquiries Following Immune Therapy Sectors Recent Market Decline
8. High Cost of Biologics and Novel Oral Agents to Treat Immune Diseases Limits Patient Access
9. Immune Pharmaceuticals Reports Third Quarter 2013 Financial Results
10. Unilife Announces Supply Agreement with MedImmune for Wearable Injectable Drug Delivery Devices
11. Sangamo BioSciences Presents Clinical Data From SB-728-T HIV Study Demonstrating Long-Term Immune Reconstitution and Reduction in the HIV DNA Reservoir In Subjects with Long-Term Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... AMBLER, Pa. , Sept. 29, 2014 /PRNewswire/ ... approval for the CNS Monitor, a medical device ... patients. The CE Mark certifies that a product ... in Europe . ... parameters including electroencephalography (EEG, or brain waves) to ...
(Date:9/29/2014)... , Sept. 29, 2014  Volcano Corporation ... focused on improving patient and economic outcomes on ... minimally invasive coronary and peripheral visualization, physiology diagnostics ... to its Board of Directors from Engaged Capital, ... response:  Volcano welcomes the perspectives ...
(Date:9/29/2014)... NEW YORK , Sept. 29, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "EU5 Sigmoidoscopes Market ... the EU5 Sigmoidoscopes market. The report provides value, ... and average prices (in US dollars) within market ... (Rigid Non-Video Sigmoidoscopes and Flexible Non-Video (Fibre) Sigmoidoscopes). ...
Breaking Medicine Technology:Moberg CNS Monitor Receives European CE Mark Approval for Advanced Neurological Monitoring 2Volcano Issues Statement Regarding Letter From Engaged Capital 2Volcano Issues Statement Regarding Letter From Engaged Capital 3EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3
... NASHVILLE, Tenn., Aug. 4, 2011 Cumberland Pharmaceuticals Inc. ... has executed a new senior credit agreement with Bank of ... its revolving line of credit to $10 million, which is ... the new facility has been extended to December 2014. ...
... Purdue Pharma, L.P., a privately held pharmaceutical ... International , a U.S.-based humanitarian organization that helps ... view the multimedia assets associated with this release, ... (Photo: http://photos.prnewswire.com/prnh/20110804/MM46982 ) Purdue ...
Cached Medicine Technology:Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 3
(Date:9/29/2014)... (PRWEB) September 30, 2014 Top10BestSEOHosting.com ... and reviews about hosting products. It is headed ... rich experience. The site offers research-based information and ... and suppliers in the current market. , ... and announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) and ...
(Date:9/29/2014)... LA (PRWEB) September 29, 2014 ... mission is to provide students with a certification ... awareness necessary to enhance their own lives, and ... Fitness Professionals also benefits the community at large, ... service focused on the professional practice of fitness, ...
(Date:9/29/2014)... September 29, 2014 Each year over ... to complaints of dizziness and imbalance. Symptoms of vestibular ... next and the population range can vary as much ... people will be seeking medical assistance for dizziness and ... from combat with post blast or post concussion injuries ...
(Date:9/29/2014)... Thousand Oaks, Calif. (PRWEB) September 29, 2014 ... and Injury Relief (PMIR) and Thousand Oaks Surgery Center ... Serra Medical Plaza, a state-of-the-art healthcare facility in Thousand ... to these two practices that offer Conejo Valley residents ... patients with acute and chronic pain, while TOSC physicians ...
(Date:9/29/2014)... The specialists from LunaDress always prides themselves on their ... of the price. To benefit more ladies, LunaDress often ... its online store. Today, the company has happily launched ... party dresses . The company’s sales manager says that ... , "We are excited to announce the new ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2Health News:Narconon Louisiana New Life Retreat Announces Stephen Mogavero Now Certified as a Personal Trainer 2Health News:North American Seminars Received PT Continuing Education Course Approval in California and Nevada and Illinois for an Online Vestibular Continuing Education Course 2Health News:New Thousand Oaks Medical Facility Hosts Grand Opening Event: Two Practices, One Celebration 2Health News:New Thousand Oaks Medical Facility Hosts Grand Opening Event: Two Practices, One Celebration 3Health News:At The Beginning Of Autumn, LunaDress Provides Huge Deals On Its Cocktail Party Dresses 2
... Thought-Leader Joins Senior Management Team, NASHVILLE, Tenn., ... of revenue cycle management and clinical communication,solutions, announced ... Senior,Vice President of Corporate Strategy, effective immediately., ... the business of healthcare,and health information technology. Most ...
... 20 Shamir Optical,Industry Ltd. (Nasdaq: SHMR ) ... on Wednesday, May 28, 2008, and has scheduled a,conference ... that morning., The conference call will be broadcast ... to http://www.kcsa.com approximately ten minutes before the,conference ...
... to be widely available for chronic pain sufferers., ... Pharma, Inc.,(Other OTC:INNP.PK - News) is pleased to ... to the Natural Pain Relief Center,non-narcotic proprietary breakthrough ... one in five Americans suffer with chronic pain ...
... to treat patients with latent tuberculosis (TB), who are infected ... less than half the time and at a lower cost ... a multi-center, randomized controlled trial. The results will be presented ... on Tuesday, May 20. , We found that using ...
... 20 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX :,HAE), ... plasma-derived protein products for commercialization,announces that Gilles ... Finance at the Montreal Sheraton Centre on ... Busines$ Meets Finance, Busines$ Meets Finance ...
... Health IT Solutions Recognized, BOSTON, May 20 ... TEPR Awards honorees during the Opening Session of,the ... Conference in,Ft. Lauderdale, Florida., TEPR Awards annually ... and solutions. The 2008 TEPR Awards honorees,are:, ...
Cached Medicine News:Health News:Emdeon Business Services Names Miriam Paramore Senior Vice President of Corporate Strategy 2Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing First Quarter 2008 Earnings Results 2Health News:Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic chronic pain treatment 2Health News:Rifampin: Latent TB treatment saves time money and lives 2Health News:Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre 2Health News:2008 TEPR Awards Honorees Announced 2
Micro-retractor arm 12"....
... designed for the retraction of nerves, vessels, tissue, ... Equalizes brain retraction pressure. Decreases shear injury to ... conjunction with the Budde Halo Retractor. Range of ... 2 mm and 4 mm wide. Quick change ...
Telescopic Diamond-Dissectors for delicate sharp tissue preparation. Total/working lengths 220/240 mm with protective sleeve....
Cone Ring Curettes, length 9" (229 mm), ring diameter (I.D.) 5/16" (8 mm)....
Medicine Products: